CD99L2 mutations cause rare movement disorder in 3,000-patient study
This digest was compiled by AI from multiple sources — links to the originals are below.
Scientists identified mutations in the CD99L2 gene as a cause of a rare movement disorder after analyzing nearly 3,000 patients with coordination and muscle control problems. The gene, previously linked only to the immune system, was found to be essential for nerve-cell communication. The discovery offers a new target for potential therapies.
The Genetic Discovery
Researchers analyzed nearly 3,000 patients with rare movement disorders affecting coordination and muscle control. They identified mutations in the CD99L2 gene, which had previously been linked only to the immune system. The study showed that CD99L2 plays an essential role in maintaining smooth nerve-cell communication.
Clinical Implications
The findings provide a new genetic target for diagnosing and potentially treating these disorders. Currently, no specific therapies exist for patients with CD99L2 mutations. The study was published in a peer-reviewed journal and involved collaboration across multiple research institutions.
What's Next
Researchers plan to investigate whether existing drugs can modulate CD99L2 function. It remains unclear how quickly these findings can translate into clinical treatments for affected patients.
1 source
CD99L2 mutations cause rare movement disorder in 3,000-patient study
